00:01
Now let's talk about the
pneumococcal polysaccharide vaccine.
00:05
Doctors give a single dose of this
vaccine to people who need it.
00:09
There are some additional
recommendations from the CDC
for people with chronic
medical conditions.
00:16
Now, I've got a whole
list for you there,
but I know you're pretty familiar with
what chronic medical conditions are.
00:22
But no, generally doctors
give a single dose.
00:26
But if the patient has a
chronic medical condition
like we have listed
there for you,
they may need an additional
one or two more doses.
00:35
I know I'm giving you
lots of information
but take a look at this,
the pneumococcal
polysaccharide vaccine
actually helps protect against twenty
three types of pneumococcal bacteria.
00:48
Now look back in your notes
at the conjugate vaccine.
00:51
Is this more or less than
the conjugate vaccine?
You got it. It's more.
00:58
Now it doesn't come
without side effects.
01:00
They'll have some mild problems
following a pneumococcal
polysaccharide vaccination.
01:05
So we're looking for reactions where the
site was given some redness, some pain,
but this should be mild.
01:12
The patient can also develop
fever or aching muscles.
01:16
These problems
should be fairly mild
and go away within
about two days.
01:20
If they persist,
the patient needs to contact
their health care provider.
01:26
Wow, I hate to even
get into this topic.
01:28
But remember, the point of
this video is to educate you
so you can make an
informed decision.
01:34
So we're going to talk
about it because we have to.
01:37
We're talking about the
effectiveness of vaccines.
01:40
Now, I'm not going
to deal an opinion
because I know there are
plenty of them out there, okay?
So I'm going to
deal with numbers
from the research
studies from the CDC.
01:51
So studies show that
for each patient
who received one dose of
pneumococcal conjugate vaccine,
here's what we see as far as impacting
people developing that type of infection.
02:03
80% fewer babies will develop
pneumococcal infection.
02:07
75% fewer patients
aged 65 years or older
will contract invasive
pneumococcal disease.
02:15
And 45 percent fewer patients
who are 65 years or older
will contract
pneumococcal pneumonia.
02:23
So pause for just a minute.
02:25
I don't think you want
to memorize these numbers
but those are some
pretty amazing statistics
of how much lower
the infection rate can be
from this particular vaccine.
02:37
Now, let's look at the pneumococcal
polysaccharide vaccine,
same thing, one dose,
between 50 to 85%
of a healthy adults
will not develop invasive
pneumococcal disease
if they received the pneumococcal
polysaccharide vaccine.